NCT01460407View on ClinicalTrials.gov

A Study to Evaluate the Effect of Clarithromycin on LY2216684

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Depressive Disorder, Major
Interventions
DRUG

LY2216684

Administered orally

DRUG

Clarithromycin

Administered orally

Trial Locations (1)

32117

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01460407 - A Study to Evaluate the Effect of Clarithromycin on LY2216684 | Biotech Hunter | Biotech Hunter